β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development
Shuyun Rao, Xiaochun Yang, Kazufumi Ohshiro, Sobia Zaidi, Zhanhuai Wang, Kirti Shetty, Xiyan Xiang, Md. Imtaiyaz Hassan, Taj Mohammad, Patricia S. Latham, Bao‐Ngoc Nguyen, Linda L. Wong, Herbert Yu, Yousef Al‐Abed, Bibhuti Mishra, Michèle Vacca, Gareth Guenigault, Michael Allison, Antonio Vidal‐Puig, Jihane N. Benhammou, Marcus Alvarez, Päivi Pajukanta, Joseph R. Pisegna, Lopa Mishra
Abstract
expression. Thus, our data indicate that SPTBN1 represents a potential target for therapeutic intervention in NASH and liver cancer.
Topics & Concepts
LipogenesisLiver cancerCancer researchSterol regulatory element-binding proteinFatty liverFibrosisCancerSteatosisEndocrinologyInternal medicineNonalcoholic fatty liver diseaseSteatohepatitisBiologyMedicineLipid metabolismDiseaseCholesterolSterolLiver Disease Diagnosis and TreatmentCancer, Lipids, and MetabolismLipid metabolism and disorders